These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7348390)

  • 41. Rabies postexposure prophylaxis--Connecticut, 1990-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Mar; 45(11):232-4. PubMed ID: 8606682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rabies postexposure management of travelers presenting to travel health clinics in Auckland and Hamilton, New Zealand.
    Shaw MT; O'Brien B; Leggat PA
    J Travel Med; 2009; 16(1):13-7. PubMed ID: 19192122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population.
    Sehgal S; Bhattacharya D; Bhardwaj M
    J Commun Dis; 1995 Mar; 27(1):36-43. PubMed ID: 7636151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Rabies control should be done from their origin].
    Tang Q; Yu YX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):1 p preceding table of contents. PubMed ID: 19031689
    [No Abstract]   [Full Text] [Related]  

  • 46. Monoclonal antibody characterization of rabies virus isolates from Russia, Finland and Estonia.
    Metlin AE; Cox J; Rybakov SS; Huovilainen A; Grouzdev KN; Neuvonen E
    J Vet Med B Infect Dis Vet Public Health; 2004 Mar; 51(2):94-6. PubMed ID: 15030608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Situation of endemic rabies in Madagascar].
    Morvan JM; Rakoto-Andrianarivelo M; Randriamihoatra S; Roux J
    Arch Inst Pasteur Madagascar; 1993; 60(1-2):5-8. PubMed ID: 8192541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine.
    Liu Y; Zhang S; Ma G; Zhang F; Hu R
    Vaccine; 2008 Oct; 26(42):5368-72. PubMed ID: 18721839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Rabies in Poland in 1997].
    Seroka D; Sadkowska-Todys M; Labuńska E
    Przegl Epidemiol; 1999; 53(1-2):137-49. PubMed ID: 10402860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Wounds from animals bites: therapy and anti-rabies prevention].
    Accettella U; Ricci S; Irace S; De Petris U; Masci M; Stagnitti F
    Clin Ter; 1983 Aug; 106(4):313-7. PubMed ID: 6627899
    [No Abstract]   [Full Text] [Related]  

  • 52. The cost of preventing rabies at any cost: post-exposure prophylaxis for occult bat contact.
    Huot C; De Serres G; Duval B; Maranda-Aubut R; Ouakki M; Skowronski DM
    Vaccine; 2008 Aug; 26(35):4446-50. PubMed ID: 18602958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human rabies--California, 1987.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 May; 37(19):305-8. PubMed ID: 3130561
    [No Abstract]   [Full Text] [Related]  

  • 54. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
    Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
    J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
    [No Abstract]   [Full Text] [Related]  

  • 55. [A study on efficacy of rabies vaccine prepared by primary hamster kidney cells in Guangxi].
    Wu T; Lu Y; Ge X
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):211-3. PubMed ID: 10322757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
    J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of oral vaccination in the final stage of fox rabies elimination in Switzerland.
    Bugnon P; Breitenmoser U; Peterhans E; Zanoni R
    J Vet Med B Infect Dis Vet Public Health; 2004 Dec; 51(10):433-7. PubMed ID: 15606866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.
    Bakker AB; Python C; Kissling CJ; Pandya P; Marissen WE; Brink MF; Lagerwerf F; Worst S; van Corven E; Kostense S; Hartmann K; Weverling GJ; Uytdehaag F; Herzog C; Briggs DJ; Rupprecht CE; Grimaldi R; Goudsmit J
    Vaccine; 2008 Nov; 26(47):5922-7. PubMed ID: 18804136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serologic response of vaccinated persons against rabies using Fuenzalida type vaccine].
    Salido-Rengell F
    Rev Invest Salud Publica; 1969; 29(2):157-68. PubMed ID: 5802753
    [No Abstract]   [Full Text] [Related]  

  • 60. [Rabies in Poland in 2005].
    Sadkowska-Todys M; Labuńska E
    Przegl Epidemiol; 2007; 61(2):291-9. PubMed ID: 17956045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.